Metabolic abnormalities and low dietary Omega 3 are associated with symptom severity and worse functioning prior to the onset of psychosis: Findings from the North American Prodrome Longitudinal Studies Consortium.

Abstract:

OBJECTIVE:Patients with schizophrenia have a high prevalence of metabolic disorders and cardiovascular mortality. It is possible that a vulnerability to metabolic abnormalities is associated with risk for psychosis, symptoms and functionality. In this study, we evaluate demographic information, cardiometabolic indices, symptoms and functioning in an antipsychotic free cohort at Clinical High Risk (CHR) for psychosis from the NAPLS Omega 3 fatty acid clinical trial. METHOD:Subjects received physical exams and metabolic monitoring prior to randomization into the Omega 3 versus Placebo trial. Anthropometrical measures, vital signs, glucose, and lipids were assessed along with symptoms, functioning, dietary Omega 3 fatty acids, erythrocyte polyunsaturated fatty acid content and a measure of lipid peroxidation (TBARS, Thiobarbituric acid-reactive substances). RESULTS:The sample included 113 CHR subjects (42.1% female; 17.5% Latino) ages 12-29. The mean BMI was 24.3 with a trend toward higher BMI and a higher incidence of metabolic syndrome in Latino subjects; 36% of the sample was obese/overweight; 37.6% met criteria for prehypertension/hypertension; 4.2% met criteria for prediabetes/diabetes; 9.6% showed evidence of insulin resistance and 44.7% had dyslipidemia. The TBARS was elevated at 9.8 μM ± 6.1 (normal 1.86-3.94 μM). Metabolic parameters and a diet low in Omega 3 rich foods were significantly associated with prodromal symptoms and poor functioning. CONCLUSIONS:CHR subjects show a high percentage of metabolic abnormalities prior to exposure to antipsychotic medication. These findings reinforce that early detection of metabolic disturbances and food insecurity is crucial since these factors are modifiable with the potential for significant gains in terms of quality of life, physical and mental health.

journal_name

Schizophr Res

journal_title

Schizophrenia research

authors

Cadenhead KS,Minichino A,Kelsven S,Addington J,Bearden C,Cannon TD,Cornblatt BA,Mathalon D,McGlashan TH,Perkins DO,Seidman LJ,Tsuang M,Walker EF,Woods SW,Yao J,North American Prodromal Longitudinal Studies (NAPLS) consortiu

doi

10.1016/j.schres.2018.09.022

subject

Has Abstract

pub_date

2019-02-01 00:00:00

pages

96-103

eissn

0920-9964

issn

1573-2509

pii

S0920-9964(18)30580-2

journal_volume

204

pub_type

杂志文章,随机对照试验
  • Verbal memory impairment in healthy siblings of patients with schizophrenia.

    abstract::Cognitive deficits have been recognized as a core feature of schizophrenia (SZ) and are present in most patients. Verbal memory (VM), working memory (WM), and executive function (EF) are domains commonly impaired in patients with SZ. These latter domains have been related to the genetic risk of the disorder characteri...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2013.08.019

    authors: Massuda R,Bücker J,Czepielewski LS,Narvaez JC,Pedrini M,Santos BT,Teixeira AS,Souza AL,Vasconcelos-Moreno MP,Vianna-Sulzbach M,Goi PD,Belmonte-de-Abreu P,Gama CS

    更新日期:2013-11-01 00:00:00

  • Identification of antibodies to heat shock proteins 90 kDa and 70 kDa in patients with schizophrenia.

    abstract:OBJECTIVES:Recent reports of antibodies to heat shock proteins 60kDa (HSP60) and HSP70 suggested that antibodies to the heat shock protein that plays a protective role against environmental stresses in a cell might be related to the pathogenesis of schizophrenia, although the antibody to HSP90 had not yet been identifi...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/s0920-9964(00)00091-8

    authors: Kim JJ,Lee SJ,Toh KY,Lee CU,Lee C,Paik IH

    更新日期:2001-10-01 00:00:00

  • Trait or state? A longitudinal neuropsychological evaluation and fMRI study in schizoaffective disorder.

    abstract::Schizoaffective patients can have neurocognitive deficits and default mode network dysfunction while being acutely ill. It remains unclear to what extent these abnormalities persist when they go into clinical remission. Memory and executive function were tested in 22 acutely ill schizoaffective patients; they also und...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2014.08.017

    authors: Madre M,Radua J,Landin-Romero R,Alonso-Lana S,Salvador R,Panicali F,Pomarol-Clotet E,Amann BL

    更新日期:2014-11-01 00:00:00

  • Relationships between smartphone social behavior and relapse in schizophrenia: A preliminary report.

    abstract::Social dysfunction is a hallmark of schizophrenia. Social isolation may increase individuals' risk for psychotic symptom exacerbation and relapse. Monitoring and timely detection of shifts in social functioning are hampered by the limitations of traditional clinic-based assessment strategies. Ubiquitous mobile technol...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.schres.2019.03.014

    authors: Buck B,Scherer E,Brian R,Wang R,Wang W,Campbell A,Choudhury T,Hauser M,Kane JM,Ben-Zeev D

    更新日期:2019-06-01 00:00:00

  • Schizophrenia, symptomatology and social inference: investigating "theory of mind" in people with schizophrenia.

    abstract::It has been proposed that certain psychotic symptoms associated with schizophrenia reflect a deficit in the ability to appreciate other people's mental states (Frith, 1992). This notion is tested using a newly devised task examining the capacity to infer intentions behind indirect speech. The findings support the noti...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/0920-9964(95)00024-g

    authors: Corcoran R,Mercer G,Frith CD

    更新日期:1995-09-01 00:00:00

  • Genetic predictors of antipsychotic response to lurasidone identified in a genome wide association study and by schizophrenia risk genes.

    abstract::Biomarkers which predict response to atypical antipsychotic drugs (AAPDs) increases their benefit/risk ratio. We sought to identify common variants in genes which predict response to lurasidone, an AAPD, by associating genome-wide association study (GWAS) data and changes (Δ) in Positive And Negative Syndrome Scale (P...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.schres.2017.04.009

    authors: Li J,Yoshikawa A,Brennan MD,Ramsey TL,Meltzer HY

    更新日期:2018-02-01 00:00:00

  • Antipsychotic drug use in pregnancy: A multinational study from ten countries.

    abstract:AIM:To compare the prevalence and trends of antipsychotic drug use during pregnancy between countries across four continents. METHODS:Individually linked health data in Denmark (2000-2012), Finland (2005-2014), Iceland (2004-2017), Norway (2005-2015), Sweden (2006-2015), Germany (2006-2015), Australia (New South Wales...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2020.03.048

    authors: Reutfors J,Cesta CE,Cohen JM,Bateman BT,Brauer R,Einarsdóttir K,Engeland A,Furu K,Gissler M,Havard A,Hernandez-Diaz S,Huybrechts KF,Karlstad Ø,Leinonen MK,Li J,Man KKC,Pazzagli L,Schaffer A,Schink T,Wang Z,Yu Y,

    更新日期:2020-06-01 00:00:00

  • Pathways to care in subjects at high risk for psychotic disorders - a European perspective.

    abstract::Evidence-based decisions on indicated prevention in early psychosis require large-scale studies on the pathways to care in high-risk subjects. EPOS (The European Prediction of Psychosis Study), a prospective multi-center, naturalistic field study in four European countries (Finland, Germany, The Netherlands and Englan...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.schres.2013.11.031

    authors: von Reventlow HG,Krüger-Özgürdal S,Ruhrmann S,Schultze-Lutter F,Heinz A,Patterson P,Heinimaa M,Dingemans P,French P,Birchwood M,Salokangas RK,Linszen D,Morrison A,Klosterkötter J,Juckel G

    更新日期:2014-02-01 00:00:00

  • Association of maternal exposure to terror attacks during pregnancy and the risk of schizophrenia in the offspring: A population-based study.

    abstract::This study tested the hypothesis that maternal exposure to terror attacks during pregnancy is associated with the risk of schizophrenia in the offspring. A population-based study was conducted of Israeli children born between 1975 and 1995 and that were registered in the Ministry of Interior and followed up in the Min...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2018.04.024

    authors: Weinstein Y,Levav I,Gelkopf M,Roe D,Yoffe R,Pugachova I,Levine SZ

    更新日期:2018-09-01 00:00:00

  • Novel rare variants in F-box protein 45 (FBXO45) in schizophrenia.

    abstract::The ubiquitin ligase F-box protein 45 (FBXO45) is critical for synaptogenesis, neuronal migration, and synaptic transmission. FBXO45 is included in the 3q29 microdeletion region that confers a significant risk for schizophrenia, as shown by rare structural variant studies. Thus, FBXO45 is considered a prominent candid...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2014.04.032

    authors: Wang C,Koide T,Kimura H,Kunimoto S,Yoshimi A,Nakamura Y,Kushima I,Banno M,Kawano N,Takasaki Y,Xing J,Noda Y,Mouri A,Aleksic B,Ikeda M,Okada T,Iidaka T,Inada T,Iwata N,Ozaki N

    更新日期:2014-08-01 00:00:00

  • Quantitative assessment of the frequency of normal associations in the utterances of schizophrenia patients and healthy controls.

    abstract:BACKGROUND:The intrusion of associations into the utterances of schizophrenic individuals typically disrupts the coherence of the patient's utterances. Recent theoretical formulations of these phenomena have emphasized the hyperactivity) of associational networks in such language disturbance (e.g., Maher, B.A. 2003 Sch...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2005.05.017

    authors: Maher BA,Manschreck TC,Linnet J,Candela S

    更新日期:2005-10-15 00:00:00

  • The efficacy of lamotrigine in clozapine-resistant schizophrenia: a systematic review and meta-analysis.

    abstract:BACKGROUND:Clozapine is the drug of choice for patients with unsatisfactory response to routine antipsychotic treatment. Polypharmacy is widely used among patients having clozapine-resistant schizophrenia, although no solid evidence exists for any effective augmentation therapy for this patient population. We aimed to ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,meta分析,评审

    doi:10.1016/j.schres.2009.01.002

    authors: Tiihonen J,Wahlbeck K,Kiviniemi V

    更新日期:2009-04-01 00:00:00

  • Effects of short-term, high-frequency repetitive transcranial magnetic stimulation to bilateral dorsolateral prefrontal cortex on smoking behavior and cognition in patients with schizophrenia and non-psychiatric controls.

    abstract:BACKGROUND:High rates of tobacco smoking and smoking cessation failure in schizophrenia may be related to prefrontal cortical dysfunction. Novel treatment options for tobacco use disorder are needed given the limited efficacy of current pharmacotherapies. Preliminary evidence suggests high-frequency repetitive transcra...

    journal_title:Schizophrenia research

    pub_type: 信件

    doi:10.1016/j.schres.2018.02.015

    authors: Kozak K,Sharif-Razi M,Morozova M,Gaudette EV,Barr MS,Daskalakis ZJ,Blumberger DM,George TP

    更新日期:2018-07-01 00:00:00

  • Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse.

    abstract::This prospective study examined the effect of medication compliance and substance abuse on 4 year outcome in 99 patients following a relapse of schizophrenia. Univariate survival analysis revealed longer community tenure in patients if they were over the age of 35 years, not admitted 2 years prior to the index episode...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/s0920-9964(01)00261-4

    authors: Hunt GE,Bergen J,Bashir M

    更新日期:2002-04-01 00:00:00

  • Pharmacokinetic-pharmacodynamic modeling of antipsychotic drugs in patients with schizophrenia Part I: the use of PANSS total score and clinical utility.

    abstract:BACKGROUND:To develop a pharmacokinetic-pharmacodynamic (PK-PD) model using individual-level data of Positive and Negative Syndrome Scale (PANSS) total score to characterize the antipsychotic drug effect taking into account the placebo effect and dropout rate. In addition, a clinical utility (CU) criterion that describ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2013.02.011

    authors: Pilla Reddy V,Kozielska M,Suleiman AA,Johnson M,Vermeulen A,Liu J,de Greef R,Groothuis GM,Danhof M,Proost JH

    更新日期:2013-05-01 00:00:00

  • Protein expression of targets of the FMRP regulon is altered in brains of subjects with schizophrenia and mood disorders.

    abstract::Fragile X mental retardation protein (FMRP) is an RNA binding protein with 842 target mRNAs in mammalian brain. Silencing of the fragile X mental retardation 1 (FMR1) gene leads to loss of expression of FMRP and upregulated metabotropic glutamate receptor 5 (mGluR5) signaling resulting in the multiple physical and cog...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2015.04.012

    authors: Folsom TD,Thuras PD,Fatemi SH

    更新日期:2015-07-01 00:00:00

  • Patient characteristics and the likelihood of initiation on olanzapine or risperidone among patients with schizophrenia.

    abstract::Although pharmacologic treatments are available for patients with schizophrenia, little is known about how prescription patterns of atypical antipsychotic agents are related to patient characteristics. In this study, we examined the association between patient characteristics and the likelihood of being initiated on o...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2005.04.005

    authors: Ren XS,Kazis LE,Lee AF,Huang YH,Hamed A,Cunningham F,Herz L,Miller DR

    更新日期:2005-09-15 00:00:00

  • Diagnosis and treatment of psychiatric disorders in children with a schizophrenic parent.

    abstract::Many children of a schizophrenic parent may inherit a portion of the genetic risk factors for schizophrenia. The frequency of DSM-IV psychopathology in children of a schizophrenic parent and the frequency and type of mental health treatment accessed by these youths is not well understood. Twenty-eight adults with schi...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/s0920-9964(00)00043-8

    authors: Ross RG,Compagnon N

    更新日期:2001-05-30 00:00:00

  • Does social cognition training augment response to computer-assisted cognitive remediation for schizophrenia?

    abstract:OBJECTIVES:Cognitive remediation therapy (CRT) has shown significant improvement in cognition in schizophrenia. However, effect sizes of CRT have been reported to be modest raising the issue how to augment the effects of CRT on neurocognition and social cognition. Our aim was to examine whether the addition of computer...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.schres.2018.06.012

    authors: Lindenmayer JP,Khan A,McGurk SR,Kulsa MKC,Ljuri I,Ozog V,Fregenti S,Capodilupo G,Buccellato K,Thanju A,Goldring A,Parak M,Parker B

    更新日期:2018-11-01 00:00:00

  • Schizophrenia and HLA: a review.

    abstract::A number of reports of genetic association of human leucocyte antigens (HLA) and alleles with schizophrenia have recently been published. A schizophrenia locus on chromosome 6p near the HLA region has also been reported, on the basis of linkage studies. We have therefore reviewed the investigations of association of H...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,评审

    doi:10.1016/s0920-9964(00)00022-0

    authors: Wright P,Nimgaonkar VL,Donaldson PT,Murray RM

    更新日期:2001-01-15 00:00:00

  • Developing models of how cognitive improvements change functioning: mediation, moderation and moderated mediation.

    abstract:BACKGROUND:Cognitive remediation (CRT) affects functioning but the extent and type of cognitive improvements necessary are unknown. AIM:To develop and test models of how cognitive improvement transfers to work behaviour using the data from a current service. METHOD:Participants (N49) with a support worker and a paid ...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2012.03.020

    authors: Wykes T,Reeder C,Huddy V,Taylor R,Wood H,Ghirasim N,Kontis D,Landau S

    更新日期:2012-06-01 00:00:00

  • The relationship between clinical and biochemical changes following neuroleptic treatment in schizophrenia.

    abstract::Clinical improvement in psychotic symptoms is not immediate when neuroleptic treatment is commenced. Previous studies have demonstrated the development of biochemical tolerance to the effects of neuroleptics on the dopamine system. This study demonstrates a relationship between this biochemical change and the clinical...

    journal_title:Schizophrenia research

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0920-9964(90)90007-t

    authors: Cooper SJ,Leahey W,Liddle J,King DJ

    更新日期:1990-07-01 00:00:00

  • Assessment of executive dysfunction during activities of daily living in schizophrenia.

    abstract::Many neuropsychological studies have described deficits of memory and executive functions in patients with schizophrenia, and the severity of these deficits seems to be determinant in predicting the community outcome of these patients [Schizophr. Bull. 26 (2000) 119]. However, neuropsychological evaluation does not pr...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2003.07.005

    authors: Semkovska M,Bédard MA,Godbout L,Limoge F,Stip E

    更新日期:2004-08-01 00:00:00

  • The components of executive functioning in a cohort of patients with chronic schizophrenia: a multiple single-case study design.

    abstract::We examined the fractionation of executive functioning performance in ninety patients with schizophrenia, who were tested for initiation, sustained attention, switching/flexibility, attention allocation and impulsivity/disinhibition. The participants were also given tests of general intelligence and memory. We analyse...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2005.08.011

    authors: Chan RC,Chen EY,Cheung EF,Chen RY,Cheung HK

    更新日期:2006-01-31 00:00:00

  • Low maternal vitamin D as a risk factor for schizophrenia: a pilot study using banked sera.

    abstract:OBJECTIVE:Evidence from epidemiology suggests that low maternal vitamin D may be a risk factor for schizophrenia. METHOD:Based on sera taken during the third trimester, we compared the level of 25 hydroxyvitamin D3 in mothers of individuals with schizophrenia or schizoaffective disorders versus mothers of unaffected c...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/s0920-9964(02)00435-8

    authors: McGrath J,Eyles D,Mowry B,Yolken R,Buka S

    更新日期:2003-09-01 00:00:00

  • General intellectual ability does not explain the general deficit in schizophrenia.

    abstract::Patients with schizophrenia demonstrate a generalized deficit across multiple cognitive domains. However, it is unknown whether this deficit is largely due to lower intelligence, or if there is an impact of schizophrenia which cannot be accounted for by measures of general intellectual ability (GIA). We created four I...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2013.04.016

    authors: Gray BE,McMahon RP,Gold JM

    更新日期:2013-07-01 00:00:00

  • Do people with schizophrenia who have objective cognitive impairment identify cognitive deficits on a self report measure?

    abstract::Individuals diagnosed with schizophrenia spectrum disorders have significant neuropsychological deficits that have been linked to poor functional outcome. As more treatments are developed and implemented for cognitive impairments, it will be important to consider whether people with schizophrenia have insight into the...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2008.07.007

    authors: Medalia A,Thysen J,Freilich B

    更新日期:2008-10-01 00:00:00

  • Neurocognitive impairment across the lifespan in schizophrenia: an update.

    abstract::A literature review and power analysis of longitudinal studies published since 1997 investigating the trajectory of neurocognitive deficits across time in patients with schizophrenia was conducted. Ten studies were identified, evaluating a total of 834 patients with mean ages of 24.0-77.8 years at study entry. Power e...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,评审

    doi:10.1016/j.schres.2004.07.005

    authors: Kurtz MM

    更新日期:2005-04-01 00:00:00

  • Late electrophysiological potentials and emotion in schizophrenia: A meta-analytic review.

    abstract:INTRODUCTION:There is mixed evidence about emotional processing abnormalities in schizophrenia and schizoaffective disorder, with self-reports and clinician ratings indicating significant differences between patients and controls, but studies of in-the-moment, self-reported emotional experience finding only small diffe...

    journal_title:Schizophrenia research

    pub_type: 杂志文章,meta分析,评审

    doi:10.1016/j.schres.2019.07.013

    authors: Castro MK,Bailey DH,Zinger JF,Martin EA

    更新日期:2019-09-01 00:00:00

  • Why you can't be in sync with schizophrenia patients.

    abstract::Most individuals with schizophrenia will be confronted with some form of stigma. In recent years, clinicians and family members have increasingly contested the term "schizophrenia". Many of them discuss changing this name, as a means to fight stigma. Up until now, surprisingly, most research has been conducted using s...

    journal_title:Schizophrenia research

    pub_type: 杂志文章

    doi:10.1016/j.schres.2019.11.054

    authors: Rainteau N,Salesse RN,Macgregor A,Macioce V,Raffard S,Capdevielle D

    更新日期:2020-02-01 00:00:00